Departments of Health Policy and Economics
George Washington University
2021 K street NW, Suite 800
Washington, DC 20037
NBER Program Affiliations:
NBER Affiliation: Research Associate
Institutional Affiliation: George Washington University
NBER Working Papers and Publications
|May 2019||Do Stricter Immunization Laws Improve Coverage? Evidence from the Repeal of Non-medical Exemptions for School Mandated Vaccines|
with Chelsea J. Richwine, Ali Moghtaderi: w25847
|November 2016||Do Good Reports Mean Higher Prices? The Impact of Hospital Compare Ratings on Cardiac Pricing|
with William Encinosa, Kathleen Carey: w22858
|August 2016||Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening|
with Ali Moghtaderi: w22523
|October 2015||Private Safety-Net Clinics: Effects of Financial Pressures and Community Characteristics on Closures|
with Suhui Li, Jesse M. Pines, Mark S. Zocchi, Renee Y. Hsia: w21648
|September 2013||Impact of Mortality-Based Performance Measures on Hospital Pricing: the Case of Colon Cancer Surgeries|
with Partha Deb, Michael Grossman, Gregory Cooper, Siran Koroukian, Fang Xu: w19447
|March 2013||How Do Hospitals Respond to Market Entry? Evidence from A Deregulated Market for Cardiac Revascularization|
with Suhui Li: w18926
Published: Suhui Li & Avi Dor, 2015. "How Do Hospitals Respond to Market Entry? Evidence from a Deregulated Market for Cardiac Revascularization," Health Economics, vol 24(8), pages 990-1008.
|January 2010||Does Prescription Drug Adherence Reduce Hospitalizations and Costs?|
with William Encinosa, Didem Bernard: w15691
Published: Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes. Encinosa, W., Bernard, D., Dor, A. "Does prescription drug adherence reduce hospitalizations and costs? The case of diabetes." Advances in Health Economics and Health Services Research, Vol. 22 151-173. Emerald Group Publishing Limited, Apr 2010.
|May 2007||End-stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing|
with Mark V. Pauly, Margaret A. Eichleay, Philip J. Held: w13125
Published: Avi Dor & Mark Pauly & Margaret Eichleay & Philip Held, 2007. "End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF)," International Journal of Health Care Finance and Economics, Springer, vol. 7(2), pages 73-111, September.
|September 2004||How Does Cost-Sharing Affect Drug Purchases? Insurance Regimes in the Private Market for Prescription Drugs |
with William Encinosa: w10738
|April 2004||Managed Care Discounting: Evidence from the MarketScan Database|
with Siran M. Koroukian, Michael Grossman: w10437
Published: Avi Dor & Siran M. Koroukian & Michael Grossman, 2004. "Managed Care Discounting: Evidence from the MarketScan Database," INQUIRY: The Journal of Health Care Organization, Provision, and Financing, vol 41(2), pages 159-169.
|March 2004||Transaction Prices and Managed Care Discounting for Selected Medical Technologies: A Bargaining Approach|
with Michael Grossman, Siran M.Koroukian: w10377
Published: Dor, Avi, Michael Grossman and Siran M. Koroukian. “Hospital Transaction Prices and Managed-Care Discounting for Selected Medical Technologies.” American Economic Review 94, 2 (May 2004): 352-356.
|June 2003||The Effects of Private Insurance on Measures of Health: Evidence from the Health and Retirement Study|
with Joseph Sudano, David W. Baker: w9774
|September 2002||Does Managerial 'Outsourcing' Reduce Expense Preference Behavior? A Comparison of Adopters and Non-Adopters of Contract-Management in US Hospitals|
with Kathleen Carey: w9157
|February 2001||Administered Prices and Suboptimal Prevention: Evidence from the Medicare Dialysis Program|
Published: Dor, Avi. "Optimal Price Rules, Administered Prices And Suboptimal Prevention: Evidence From A Medicare Program," Journal of Regulatory Economics, 2004, v25(1,Jan), 81-104.